Newsletter | September 24, 2024

09.24.24 -- Should You Be Using Unique Container Identification?

SPONSOR

A Full-Service Solution Partner Disrupting the Outsourcing Paradigm

inSeption Group offers a full-service solution designed to disrupt the current outsourcing paradigm, resurrecting a common-sense approach to rebuild business trust and confidence in a client’s selected vendor. Primarily focused on oncology, hematology, neurodegenerative disorders, and rare/orphan disease indications, with a specialization in cell and gene therapy, inSeption has been a solution for its’ clients who have experienced the progressive degradation of today’s outsourcing options. Contact them.

FEATURED EDITORIAL

Should You Be Using Unique Container Identification?

Unique identifiers on glass vials could solve a host of problems. ISPE developed a new guide to help manufacturers apply them on primary parenteral containers.

INDUSTRY INSIGHTS

Build A Foundation For Successful Clinical Manufacturing

Establishing both the QTPP and CQA for your drug at the beginning of the product lifecycle is crucial for a successful GMP manufacturing process.

Proactive Strategies To Evaluate And Mitigate Clinical Supply Risk

Learn about strategies that can help build an understanding of risk assessment, in addition to how a study’s protocol requirements, drug characteristics, packaging specifications, and patient compliance concerns must be identified and addressed.

SOLUTIONS

Supply Chain Logistics Experts Share Best Practices

Pharmaceutical Clinical Trial Distribution Services